


Ask a doctor about a prescription for ZONISAMIDE STADA 25 mg HARD CAPSULES
Package Leaflet: Information for the User
Zonisamide STADA 25 mg hard capsules EFG
Zonisamide STADA 50 mg hard capsules EFG
Zonisamide STADA 100 mg hard capsules EFG
Read the entire package leaflet carefully before you start taking this medicine, as it contains important information for you.
Contents of the package leaflet
This medicine contains the active substance zonisamide and is used as an antiepileptic.
Zonisamide is used to treat partial seizures (seizures that affect only a part of the brain) that may or may not be followed by a generalized seizure (a seizure that affects the whole brain).
Zonisamide may be used:
Do not take Zonisamide Stada:
Warnings and precautions
Zonisamide belongs to a group of medicines (sulfonamides) that can cause severe allergic reactions, serious skin rashes, and blood disorders, which can very rarely be life-threatening (see section 4. Possible side effects).
There have been reports of serious skin rashes associated with zonisamide therapy, including cases of Stevens-Johnson syndrome.
Consult your doctor or pharmacist before taking zonisamide:
Zonisamide may cause high levels of ammonia in the blood, which could change brain function, especially if you are also taking other medicines that can increase ammonia levels (e.g., valproate), if you have a genetic disorder that causes too much ammonia to be produced in the body (urea cycle disorder), or if you have liver disease. Tell your doctor immediately if you feel unusually sleepy or confused.
If any of these statements apply to you, tell your doctor before taking zonisamide.
Children and adolescents
Consult your doctor about the following risks:
Prevention of excessive heat and dehydration in children Zonisamide can cause your child to sweat less or have excessive heat; this can cause brain damage and death if not treated. Children are the most vulnerable population, especially on hot days. While your child is taking zonisamide:
If your child's skin is very hot with little or no sweating, the child feels confused or has muscle cramps, or their heart rate or breathing is fast.
|
Do not give this medicine to children under 6 years old, as it is not known if the potential benefits are greater than the risks in this age group.
Other medicines and Zonisamide Stada
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
Taking Zonisamide Stada with food and drinks
Zonisamide can be taken with or without food.
Pregnancy, breastfeeding, and fertility
Women of childbearing age must use effective contraception during treatment with zonisamide and for one month after stopping zonisamide.
If you plan to become pregnant, talk to your doctor before stopping contraception and before becoming pregnant about the possibility of switching to other suitable treatments. If you are or think you may be pregnant, tell your doctor immediately. Do not stop treatment without consulting your doctor.
You should only take zonisamide during pregnancy if your doctor advises it. Research shows a higher risk of birth defects in children of women who take antiepileptics. The risk of birth defects or developmental neurological disorders (problems with brain development) for your child after taking zonisamide during pregnancy is not known. A study showed that children whose mothers used zonisamide during pregnancy were smaller than expected for their age at birth, compared to children whose mothers were treated with lamotrigine monotherapy. Make sure you are fully informed about the risks and benefits of using zonisamide for epilepsy during pregnancy.
Do not breastfeed while taking zonisamide or for one month after stopping zonisamide.
There are no clinical data on the effects of zonisamide on human fertility. Animal studies have shown changes in fertility parameters.
Driving and using machines
Zonisamide may affect your concentration, ability to react/respond, and may make you feel sleepy, especially at the start of treatment or after a dose increase. If zonisamide affects you in this way, be extra careful when driving or using machines.
Zonisamide Stada contains sodium
This medicine contains less than 23 mg of sodium (1 mmol) per capsule; this is essentially "sodium-free".
Follow the instructions for administration of this medicine exactly as told by your doctor. If you are unsure, consult your doctor or pharmacist again.
The recommended dose in adults is:
If you are taking only zonisamide:
If you are taking zonisamide with other antiepileptics:
Use in children (6 to 11 years) and adolescents (12 to 17 years) who weigh at least 20 kg:
Example: a child who weighs 25 kg should take 25 mg once a day during the first week, and then the daily dose should be increased by 25 mg at the start of each week until the daily dose of 150 to 200 mg is reached.
If you think the effect of zonisamide is too strong or too weak, talk to your doctor or pharmacist.
If you take more Zonisamide Stada than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone: 91 562 04 20, stating the medicine and the amount taken.
You may feel drowsy and may lose consciousness. You may also feel like vomiting, have stomach pain, muscle spasms, eye movements, feel like you are going to faint, have a slow heart rate, and decreased kidney function and breathing rate. Do not attempt to drive.
If you forget to take Zonisamide Stada
If you stop taking Zonisamide Stada
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Zonisamide belongs to a group of medicines (sulfonamides) that can cause severe allergic reactions, serious skin rashes, and blood disorders, which can very rarely be life-threatening.
Get medical help immediately if
Get medical help as soon as possible if
Your doctor may decide that you should stop taking zonisamide.
The most common side effects of zonisamide are all mild. They occur during the first month of treatment and often decrease as treatment continues. In children aged 6 to 17 years, the side effects were consistent with those described below, except for the following: pneumonia, dehydration, decreased sweating (frequent), and abnormal liver enzymes (uncommon).
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Rare side effects(may affect up to 1 in 10,000 people):
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly to the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and on the carton after "EXP". The expiry date refers to the last day of the month stated.
This medicine does not require any special storage conditions.
Do not use this medicine if you notice any signs of deterioration in the capsules, blister, or carton, or any visible signs of deterioration in the medicine. Return the package to your pharmacist.
Medicines should not be disposed of via wastewater or household waste. Deposit the packages and medicines you no longer need at the SIGRE point in your pharmacy. If in doubt, ask your pharmacist how to dispose of packages and medicines you no longer need. This will help protect the environment.
Composition of Zonisamida Stada
The active ingredient is zonisamide. Zonisamida Stada 25 mg hard capsules contain 25 mg of zonisamide. Zonisamida Stada 50 mg hard capsules contain 50 mg of zonisamide. Zonisamida Stada 100 mg hard capsules contain 100 mg of zonisamide.
The other ingredients present in the capsule content are:
Appearance of the Product and Package Contents
Zonisamida Stada 25 mg hard capsules are size No. 4 capsules, with a white opaque body and a white opaque capsule cap, 14.4 mm in length, and marked with "Z25" in black.
Zonisamida Stada 50 mg hard capsules are size No. 3 capsules, with a white opaque body and a white opaque capsule cap, 15.8 mm in length, and marked with "Z50" in red.
Zonisamida Stada 100 mg hard capsules are size No. 1 capsules, with a white opaque body and a white opaque capsule cap, 19.3 mm in length, and marked with "Z100" in black.
The Zonisamida Stada capsules are packaged in blisters, which are then packaged in boxes. The 25 mg packages contain: 14 or 28 capsules, the 50 mg packages contain 28 or 56 capsules, and the 100 mg packages contain 56 capsules.
Only some package sizes may be marketed.
Marketing Authorization Holder
Laboratorio STADA, S.L.
Frederic Mompou, 5
08960 Sant Just Desvern (Barcelona)
Spain
Manufacturer
Noucor Health S.A.
Av. Camí Reial 51-57
08184 Palau-Solità i Plegamans (Barcelona)
Spain
Date of the Last Revision of this Leaflet: March 2023
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.es)
The average price of ZONISAMIDE STADA 25 mg HARD CAPSULES in October, 2025 is around 4.85 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ZONISAMIDE STADA 25 mg HARD CAPSULES – subject to medical assessment and local rules.